Search Results - "BUEE, L"
-
1
Neurotrophic factors in Alzheimer’s disease: role of axonal transport
Published in Genes, brain and behavior (01-02-2008)“…Neurotrophic factors (NTF) are small, versatile proteins that maintain survival and function to specific neuronal populations. In general, the axonal transport…”
Get full text
Journal Article -
2
Prediction of pathology in primary progressive language and speech disorders
Published in Neurology (05-01-2010)“…Frontotemporal lobar degeneration (FTLD) encompasses a variety of clinicopathologic entities. The antemortem prediction of the underlying pathologic lesions is…”
Get full text
Journal Article -
3
Association of plasma amyloid β with risk of dementia: The prospective Three-City Study
Published in Neurology (15-09-2009)“…Several lines of evidence indicate that a decrease in the CSF concentration of amyloid beta(42) (Abeta(42)) is a potential biomarker for incident Alzheimer…”
Get full text
Journal Article -
4
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
Published in Molecular psychiatry (01-11-2013)“…Genome-wide association studies (GWAS) have identified a region upstream the BIN1 gene as the most important genetic susceptibility locus in Alzheimer’s…”
Get full text
Journal Article -
5
Current and emerging avenues for Alzheimer's disease drug targets
Published in Journal of internal medicine (01-10-2019)“…Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a global epidemic, and so far, there is neither cure nor treatment to alter its…”
Get full text
Journal Article -
6
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
Published in Neurology (12-04-1999)“…To determine the spatiotemporal mapping of neurofibrillary degeneration (NFD) in normal aging and the different stages of AD. The pathophysiologic significance…”
Get full text
Journal Article -
7
The free plasma amyloid Aβ 1 - 42 /Aβ 1 - 40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ 1 - 42 /Aβ 1 - 40 ratio. The BALTAZAR study
Published in Neurobiology of disease (01-04-2024)“…Blood-based biomarkers are a non-invasive solution to predict the risk of conversion of mild cognitive impairment (MCI) to dementia. The utility of free plasma…”
Get full text
Journal Article -
8
Neurogenesis and cell cycle‐reactivated neuronal death during pathogenic tau aggregation
Published in Genes, brain and behavior (01-02-2008)“…The aim of the present study was to investigate the relation between neurogenesis, cell cycle reactivation and neuronal death during tau pathology in a novel…”
Get full text
Journal Article -
9
A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly
Published in Molecular psychiatry (01-12-2014)“…Amyloid beta (Aβ) peptides are the major components of senile plaques, one of the main pathological hallmarks of Alzheimer disease (AD). However, Aβ peptides'…”
Get full text
Journal Article -
10
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease
Published in Molecular psychiatry (01-01-2009)“…To more rapidly identify candidate genes located within chromosomal regions of interest defined by genome scan studies in Alzheimer's disease (AD), we have…”
Get full text
Journal Article -
11
Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP-17 and Pick's Disease
Published in Brain pathology (Zurich, Switzerland) (01-10-1999)“…Neurodegenerative disorders referred to as tauopathies have cellular hyperphosphorylated tau protein aggregates in the absence of amyloid deposits. Comparative…”
Get full text
Journal Article -
12
Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors
Published in Gene therapy (01-03-2013)“…Glioblastomas are the most aggressive of the brain tumors occurring in adults and children. Currently available chemotherapy prolongs the median survival time…”
Get full text
Journal Article -
13
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats
Published in Experimental neurology (01-04-2008)“…Neurofibrillary degeneration is often observed in the brain of patients with type 1 myotonic dystrophy (DM1). It consists principally of the aggregation of Tau…”
Get full text
Journal Article -
14
Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology
Published in Molecular psychiatry (01-06-2017)“…A recent genome-wide association meta-analysis for Alzheimer’s disease (AD) identified 19 risk loci (in addition to APOE ) in which the functional genes are…”
Get full text
Journal Article -
15
Proteasome inhibition and Tau proteolysis: an unexpected regulation
Published in FEBS letters (03-01-2005)“…Increasing evidence suggests that an inhibition of the proteasome, as demonstrated in Parkinson’s disease, might be involved in Alzheimer’s disease. In this…”
Get full text
Journal Article -
16
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
Published in Brain Research Reviews (01-08-2000)“…Tau proteins belong to the family of microtubule-associated proteins. They are mainly expressed in neurons where they play an important role in the assembly of…”
Get full text
Journal Article -
17
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Published in Nature (London) (01-10-1996)Get full text
Journal Article -
18
Tau pathology: a marker of neurodegenerative disorders
Published in Current opinion in neurology (01-08-2000)“…Tau is not only a basic component of neurofibrillary degeneration, but is also an aetiological factor, as demonstrated by mutations on the tau gene responsible…”
Get full text
Journal Article -
19
Brain Microvascular Changes in Alzheimer's Disease and Other Dementias
Published in Annals of the New York Academy of Sciences (01-01-1997)“…Vasculopathy in Alzheimer's disease (AD) may represent an important pathogenetic factor of this disorder. In the present study, microvasculature was studied by…”
Get full text
Journal Article -
20